Elsayed I. Salim

1.5k total citations
71 papers, 1.1k citations indexed

About

Elsayed I. Salim is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Elsayed I. Salim has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Surgery. Recurrent topics in Elsayed I. Salim's work include Cancer-related Molecular Pathways (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Elsayed I. Salim is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Inflammatory mediators and NSAID effects (7 papers). Elsayed I. Salim collaborates with scholars based in Egypt, Japan and Saudi Arabia. Elsayed I. Salim's co-authors include Shoji Fukushima, Hideki Wanibuchi, Keiichirou Morimura, Ehab M. M. Ali, Anna Kinoshita, Malcolm A Moore, Abeer A. Khamis, Mohammed A. El‐Magd, Mohammad M. Abd‐Alhaseeb and Abdul Rahman Jazieh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Elsayed I. Salim

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsayed I. Salim Egypt 20 354 208 151 138 115 71 1.1k
Matteo Mozzicafreddo Italy 26 725 2.0× 186 0.9× 83 0.5× 86 0.6× 81 0.7× 81 1.7k
Erik J M Konings Netherlands 25 340 1.0× 139 0.7× 114 0.8× 63 0.5× 200 1.7× 41 2.2k
Ramtej J. Verma India 26 419 1.2× 188 0.9× 244 1.6× 223 1.6× 77 0.7× 123 2.1k
Kaiser Jamil India 26 468 1.3× 178 0.9× 280 1.9× 112 0.8× 73 0.6× 128 2.0k
Masanao Yokohira Japan 19 304 0.9× 153 0.7× 92 0.6× 33 0.2× 73 0.6× 80 941
Hurng‐Wern Huang Taiwan 20 668 1.9× 166 0.8× 223 1.5× 143 1.0× 86 0.7× 47 1.4k
Vinothkumar Rajamanickam China 23 595 1.7× 97 0.5× 155 1.0× 62 0.4× 37 0.3× 34 1.2k
Yong Ma China 26 866 2.4× 195 0.9× 274 1.8× 73 0.5× 204 1.8× 88 1.7k
Hiroshi Aoyama Brazil 26 888 2.5× 119 0.6× 62 0.4× 36 0.3× 130 1.1× 107 2.1k
Hak-Ryul Kim South Korea 24 923 2.6× 166 0.8× 243 1.6× 75 0.5× 126 1.1× 89 2.0k

Countries citing papers authored by Elsayed I. Salim

Since Specialization
Citations

This map shows the geographic impact of Elsayed I. Salim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsayed I. Salim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsayed I. Salim more than expected).

Fields of papers citing papers by Elsayed I. Salim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsayed I. Salim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsayed I. Salim. The network helps show where Elsayed I. Salim may publish in the future.

Co-authorship network of co-authors of Elsayed I. Salim

This figure shows the co-authorship network connecting the top 25 collaborators of Elsayed I. Salim. A scholar is included among the top collaborators of Elsayed I. Salim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsayed I. Salim. Elsayed I. Salim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Salim, Elsayed I., et al.. (2024). Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells. BMC Complementary Medicine and Therapies. 24(1). 185–185. 6 indexed citations
4.
5.
6.
7.
Donia, Thoria, et al.. (2021). Trichostatin A sensitizes hepatoma cells to Taxol more than 5-Aza-dC and dexamethasone. Drug Metabolism and Personalized Therapy. 36(4). 299–309. 2 indexed citations
8.
Khamis, Abeer A., et al.. (2018). Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Biomedicine & Pharmacotherapy. 105. 1335–1343. 100 indexed citations
9.
Salim, Elsayed I., et al.. (2015). Antitumoral and Antioxidant Potential of Egyptian Propolis Against the PC3 Prostate Cancer Cell Line. Asian Pacific Journal of Cancer Prevention. 16(17). 7641–7651. 29 indexed citations
10.
11.
Salim, Elsayed I., et al.. (2008). Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. International Journal of Cancer. 123(3). 601–608. 49 indexed citations
12.
Kakuni, Masakazu, Hideki Wanibuchi, Anna Kinoshita, et al.. (2006). Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.. PubMed. 7(2). 274–8. 6 indexed citations
13.
Doi, Kenichiro, Hideki Wanibuchi, Elsayed I. Salim, et al.. (2005). Lack of large intestinal carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine at low doses in rats initiated with azoxymethane. International Journal of Cancer. 115(6). 870–878. 19 indexed citations
14.
Shen, Jun, et al.. (2004). Inhibition of azoxymethane-induced colon carcinogenesis in rats due to JTE-522, a selective cyclooxygenase-2 inhibitor.. PubMed. 5(3). 253–8. 3 indexed citations
15.
Wanibuchi, Hideki, Elsayed I. Salim, Anna Kinoshita, et al.. (2004). Understanding arsenic carcinogenicity by the use of animal models. Toxicology and Applied Pharmacology. 198(3). 366–376. 67 indexed citations
16.
Doi, Kenichiro, Hideki Wanibuchi, Elsayed I. Salim, et al.. (2003). Revised rat multi-organ carcinogenesis bioassay for whole-body detection of chemopreventive agents: modifying potential of S-methylcysteine. Cancer Letters. 206(1). 15–26. 7 indexed citations
17.
Salim, Elsayed I. & Shoji Fukushima. (2003). Chemopreventive Potential of Volatile Oil From Black Cumin (Nigella sativa L.) Seeds Against Rat Colon Carcinogenesis. Nutrition and Cancer. 45(2). 195–202. 97 indexed citations
18.
Am, Romanenko, Keiichirou Morimura, Hideki Wanibuchi, et al.. (2000). Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident. International Journal of Cancer. 86(6). 790–798. 37 indexed citations
19.
Morimura, Keiichirou, Elsayed I. Salim, Shinji Yamamoto, Hideki Wanibuchi, & Shoji Fukushima. (1999). Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Letters. 138(1-2). 81–85. 10 indexed citations
20.
Yamamoto, Shinji, Min Wei, Chyi‐Chia Richard Lee, et al.. (1999). Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Letters. 135(2). 137–144. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matteo Mozzicafreddo Breakdown of academic impact, for papers by Erik J M Konings Breakdown of academic impact, for papers by Ramtej J. Verma Breakdown of academic impact, for papers by Kaiser Jamil Breakdown of academic impact, for papers by Masanao Yokohira Breakdown of academic impact, for papers by Hurng‐Wern Huang Breakdown of academic impact, for papers by Vinothkumar Rajamanickam Breakdown of academic impact, for papers by Yong Ma Breakdown of academic impact, for papers by Hiroshi Aoyama Breakdown of academic impact, for papers by Hak-Ryul Kim
Rankless by CCL
2026